Skip to main content

WPI 2510 Pill - white round, 9mm

Pill with imprint WPI 2510 is White, Round and has been identified as Budesonide Extended-Release 9 mg. It is supplied by Actavis Pharma, Inc.

Budesonide is used in the treatment of Inflammatory Bowel Disease; Crohn's Disease; Asthma; Asthma, Maintenance; Crohn's Disease, Maintenance and belongs to the drug classes glucocorticoids, inhaled corticosteroids. Risk cannot be ruled out during pregnancy. Budesonide 9 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2510

Budesonide extended-release 9 mg WPI 2510

Budesonide Extended-Release

Imprint
WPI 2510
Strength
9 mg
Color
White
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Glucocorticoids, Inhaled corticosteroids
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-2510
Inactive Ingredients
silicon dioxide, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), ferrosoferric oxide, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), methacrylic acid - methyl methacrylate copolymer (1:2), microcrystalline cellulose, polyethylene glycol 400, polysorbate 80, propylene glycol, sodium starch glycolate type A potato, soya lecithin, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer